Investor clashes with Akorn board after botched Fresenius tie-up
Credit: iStock.com/okskaz
An investor has urged an Illinois federal court to disregard Akorn’s motion to dismiss their lawsuit, after a merger between the drugmaker and healthcare company Fresenius collapsed following revelations that the drugmaker misrepresented the state of its data.
To read more
Subscribe to Global Data Review
Subscribe and start reading now
The one-stop information source and community touchpoint, with coverage from across the areas of
- Data protection
- Cybersecurity
- IP
- IT
- TMT
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10